Département de chimie moléculaire

Chemical and Biological Evaluations of an 111In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model., Ahmadi, Mitra, Sancey Lucie, Briat Arnaud, Riou Laurent, Boturyn Didier, Dumy Pascal, Fagret Daniel, Ghezzi Catherine, and Vuillez Jean-Philippe. , Cancer Biother. Radiopharm., Volume 23, Number 6, p.691–700, (2008)

Non-invasive tools for detecting vulnerable atherosclerotic plaques., Fagret, Daniel, Ghezzi Catherine, Dumy Pascal, Riou Laurent, and Boturyn Didier , (2010)

Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin $\alpha$v$\beta$3 targeting using single photon emission computed tomography and optical imaging., Briat, Arnaud, Wenk Christiane H. F., Ahmadi Mitra, Claron Michael, Boturyn Didier, Josserand Veronique, Dumy Pascal, Fagret Daniel, Coll Jean-Luc, Ghezzi Catherine, et al. , Cancer Sci., Volume 103, Number 6, p.1105–1110, (2012)

Targeted radionuclide therapy with RAFT-RGD radiolabelled with 90Y or 177Lu in a mouse model of $\alpha$v$\beta$3-expressing tumours., Bozon-Petitprin, A, Bacot S, Gauchez A S., Ahmadi M, Bourre J C., Marti-Batlle D, Perret P, Broisat A, Riou L M., Claron M, et al. , Eur. J. Nucl. Med. Mol. Imaging, Volume 42, Number 2, p.252–263, (2015)